Nature Communications (May 2019)

Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor

  • Jemima Ho,
  • Xuexin Yang,
  • Spyridoula-Angeliki Nikou,
  • Nessim Kichik,
  • Andrew Donkin,
  • Nicole O. Ponde,
  • Jonathan P. Richardson,
  • Remi L. Gratacap,
  • Linda S. Archambault,
  • Christian P. Zwirner,
  • Celia Murciano,
  • Rhonda Henley-Smith,
  • Selvam Thavaraj,
  • Christopher J. Tynan,
  • Sarah L. Gaffen,
  • Bernhard Hube,
  • Robert T. Wheeler,
  • David L. Moyes,
  • Julian R. Naglik

DOI
https://doi.org/10.1038/s41467-019-09915-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 12

Abstract

Read online

Candida albicans is an opportunistic fungus primarily affecting immunocompromised patients. Here, the authors identify a novel mechanism of host immune stimulation and highlight candidalysin and EGFR signalling components as potential targets for prophylactic and therapeutic intervention of mucosal candidiasis.